Drug profile · INN
indacaterol + glycopyrronium + mometasone
ENERZAIR BREEZHALER
- Patents linked
- 0
- News articles
- 0
Quick answer
indacaterol + glycopyrronium + mometasone (ENERZAIR BREEZHALER) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.
Key facts
INN indacaterol + glycopyrronium + mometasone
Brand ENERZAIR BREEZHALER
Originator Novartis Pharmaceuticals
Frequently asked questions
What is indacaterol + glycopyrronium + mometasone?
indacaterol + glycopyrronium + mometasone (ENERZAIR BREEZHALER) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.
What is the brand name for indacaterol + glycopyrronium + mometasone?
ENERZAIR BREEZHALER is a marketed brand name for indacaterol + glycopyrronium + mometasone. Check FDA Drugs@FDA for the current US label holder and prescribing information.